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detected from 47% (21/45) during the 
3-month period immediately after vac-
cine introduction (March 2006–May 
2006) to 100% (11/11) during the same 
3-month period 1 year after the vac-
cine introduction (March 2007–May 
2007) (4). We believe that our ﬁ  ndings 
are consistent with results of ﬁ  eld trials 
that indicated that the vaccine provided 
relatively less protection against P[4]
G2 strains than against other rotavirus 
strain types (5).
The beneﬁ  cial impact of rotavirus 
vaccination in northeastern Brazil is 
reﬂ  ected in the reduction of the detec-
tion rate of rotavirus among severe 
diarrhea cases in our study in Recife, 
which fell from 27% (45/166 cases) to 
5.0% (11/221 cases) in the postvac-
cine 3-month reporting periods, re-
spectively (4). Our data from Aracaju 
are indicative of heterotypic protec-
tion, although this is not statistically 
signiﬁ  cant (1), against P[4]G2 strains. 
Further postlicensure studies in Brazil 
are required to document continuing 
effectiveness of the national vacci-
nation program as well as to closely 
monitor the circulating rotavirus strain 
types (6).
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Erratum: Vol. 14, No. 4 
In the article “Reassortant Avian Inﬂ  uenza Virus (H5N1) in Poultry, Nigeria, 2007” by I. Monne et al., the author 
afﬁ  liations contained errors. Isabella Monne, Tony M. Joannis, Alice Fusaro, Paola De Benedictis, Giovanni Cattoli, 
and Ilaria Capua are afﬁ  liated with Istituto Zooproﬁ  lattico Sperimentale delle Venezie, Legnaro, Padova, Italy. 
We regret any confusion this error may have caused. 
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